BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190126
DTEND;VALUE=DATE:20190228
DTSTAMP:20260730T041930
CREATED:20190126T103447Z
LAST-MODIFIED:20190126T103614Z
UID:21033-1548460800-1551311999@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:How to Apply\nA cover letter is required for consideration for this position and should be attached as the first page of your resume. The cover letter should address your specific interest in the position and outline skills and experience that directly relate to this position. \nResponsibilities\nA post-doctoral position is immediately available to study the role of the chromatin remodeling factor ATRX in pediatric high-grade glioma. This is an exciting project that combines genetically engineered mouse models with genetic and epigenetic analysis performed under the supervision of Dr. Koschmann (Department of Pediatrics). The position will be supported by the Chad Carr Pediatric Brain Tumor Center\, and inclose collaboration with Dr. Sriram Venneti (Department of Pathology and Department of Pediatrics).\nThe successful applicant will be responsible for designing and performing studies of a novel genetically engineered intra-uterine electroporation (IUE) mouse model of brain tumors with genetic and epigenetic profiling \nRequired Qualifications\nThe successful applicant will have PhD in Cancer\, Neuroscience\, Epigenetics\, or related area of molecular or cellular biology. Expertise in molecular and cellular biology techniques including molecular cloning\, cell culture\, gene transfection/transduction\, RNA\, DNA\, and protein studies is essential. \nDesired Qualifications\nPrior experience with gene editing and chromatin immunoprecipitation will be considered an asset. Experience with murine models of neurology-base disease and/or in vivo tumor studies is preferred. \nBackground Screening\nMichigan Medicine conducts background screening and pre-employment drug testing on job candidates upon acceptance of a contingent job offer and may use a third party administrator to conduct background screenings. Background screenings are performed in compliance with the Fair Credit Report Act. Pre-employment drug testing applies to all selected candidates\, including new or additional faculty and staff appointments\, as well as transfers from other U-M campuses.
URL:https://ces.b2sg.org/event/26jan19/
LOCATION:University of Michigan\, 500 S State St\, Ann Arbor\, MI\, 48109\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/uni-michigan.jpg
END:VEVENT
END:VCALENDAR